Severe cicatricial alopecia as a rare cutaneous side effect due to erlotinib – case report
Introduction . Epidermal growth factor receptor inhibitors (EGFRI) are commonly used in the treatment of solid tumors. Cutaneous side effects occur in 80% of patients and are the most frequent adverse events. However, cicatricial alopecia is a rarely described side effect of EGFRI. Objective . To...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-10-01
|
Series: | Przegląd Dermatologiczny |
Subjects: | |
Online Access: | https://www.termedia.pl/Severe-cicatricial-alopecia-as-a-rare-cutaneous-side-effect-due-to-erlotinib-case-report,56,28518,1,1.html |